The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol
Status:
Recruiting
Trial end date:
2022-05-21
Target enrollment:
Participant gender:
Summary
This is multicenter, open-label, 2-part crossover study. Eligible subjects will have
metastatic or unresectable solid tumors. This study includes a pretreatment and treatment
phase. The pretreatment phase consists of screening and baseline. The treatment phase
consists of Periods 1 and 2 (Part A), Treatment (Part B), and Follow-up.